A randomized, double-blind, placebo controlled, multicenter, parallel-arm study assessing the efficacy, safety, and dose-response of ramipril for the treatment of hypertension in children and adolescents
Phase of Trial: Phase III
Latest Information Update: 08 Jun 2012
At a glance
- Drugs Ramipril (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms TOPHAT-II
- Sponsors King Pharmaceuticals
- 15 Apr 2009 Results presented at PAS 2009.
- 08 Feb 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 03 Dec 2006 New trial record.